Constantine A. Mantz
MD, FACRO
Radiation Oncologist
Languages spoken
English, French, Greek
Expert in
Prostate cancer, Breast cancer
Overview
Dr. Mantz joined GenesisCare in 2000 and serves as its Chief Policy Officer and Chief Physician Executive. He formerly served as Chief Medical Officer and Senior Vice President of Clinical Operations. As an area expert, he leads GenesisCare's focus on studying and treating prostate and breast cancer.
He is board-certified in Radiation Oncology by the American Board of Radiology. Dr. Mantz received his Bachelor of Science in Biology from the Loyola University of Chicago, IL, and his medical degree from the University of Chicago Pritzker School of Medicine, Chicago, IL.
.svg){kind=icon}
Career Positions
Current position(s)
- GenesisCare - Chief Medical Officer and Radiation Oncologist, Fort Myers, FL
Education
Universities
- Loyola University of Chicago, BS, Biology, Chicago, IL
- University of Chicago Pritzker School of Medicine, Chicago, IL
Residencies
- University of Chicago Hospitals, Radiation Oncology, Chicago, IL
Internships
- Hennepin County Medical Center, General Surgery, Minneapolis, MN
Expertise And Interests
Interests
- Prostate, Breast, Lung, Colorectal, Head and Neck Malignancies
Professional associations
Accomplishments
Awards and honors
- Previously chief Medical Officer for 21st Century Oncology, Numerous Radiation Therapy Research Projects Publishing Peer Reviewed Articles in Professional Publications
Publications
- Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy
- A Medicare Claims Analysis of Racial and Ethnic Disparities in the Access to Radiation Therapy Services. View publication
- The ASTRO Perspective on "Impact of Patient Stage and Disease Characteristics on the Proposed Radiation Oncology Alternative Payment Model (RO-APM) at a Large Academic Cancer Center"
- Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
- Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.
- Multi-institutional Analysis of Prostate-Specific Antigen Kinetics Following Stereotactic Body Radiotherapy (SBRT).
Presentations
Pragmatic test of amino acid mixture/enterade ® for Gastrointestinal Toxicity in Cancer therapy
Steven Finkelstein, Constantine Mantz, Laura Luque, Paul Okunieff, 2017, Multinational Association of Supportive Care in Cancer (MASCC)
Z123020151
R. Allison, D. Remonde, S. Salenius, A. Hnatov, C. Ballenger, C. Mantz, E. Fernandez, S. Finkelstein, 2016, ESTRO
Z122720162
Eduardo Fernandez, Marshal Lieberfarb, Anesa Ahamad, Jeffrey Forman, Sharon Salenius, Rudi Ross, Constantine Mantz, 2017, ACRO
Z121020143
G.Olivera, S.Mo., S.Key, D.Parnell, Y.Chen, G.Fordyce, E.Fernandez, C.Mantz, S.Finkelstein, D.Galmarini, 2015, Varian Research Partnership Symposium
Z120920142
Dioval A. Remonde, BS, Ron R. Allison,MD, Sharon A. Salenius, MPH, Andrej Hnatov, MD, Cynthia Ballenger, MD, Constantine A. Mantz, MD, Eduardo Fernandez,MD,PhD, Steven E. Finkelstein,MD, 2015, ARS
Z120920141
Francisco A. Myslicki, Jesse Shulman, Sharon Salenius, Neal Shore, Constantine Mantz, Eduardo Fernandez, Steven E. Finkelstein, 2015, ARS
Z101920161
D. A. Hamstra, N. F. Mariados, D. K. Shah, S. M. Kurtzman, J. E. Sylvester, S. H. Zimberg, R. S. Hudes, L. Karsh, M. D. Logsdon, D. C. Beyer, M. Kos, R. A. Hsi, K. Forsythe, E. M. Soffen, P. M. Francke, H. Zhang, T. L. DeWeese, R. J. Ellis II, C. A. Mantz, W. R. Bosch, and J. M. Michalski;, 2016, ASTRO
Z091420167
Finkelstein SE, Salenius S, Cross CK, Allison RR, Shafman T, Mantz C, Fernandez E, 2016, ASCO
Z091420165
Johnson SB, Soulos PR, Shafman TD, Mantz CA, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, Yu JB, 2016, ASTRO
Z091420162
Finkelstein SE, Forman J, Fernandez E, Chen C, Lieberfarb M, Salenius SA, Shafman T, and Mantz CA, 2016, ASTRO
Z083120151
Martinez A, Olivera G, Ghilezan M, Forman J, Kestin L, Finkelstein S, Mo X, Key S, Mantz C, Fernandez E, Galmarini D, et al., 2015, ASTRO Annual Meeting
Z061520154
Allison R, Salenius SA, Hnatov A, Ballenger D, Lichtblau D, Mantz CA, Fernandez E, Finkelstein SE, 2015, ASTRO Annual Meeting
Z061520152
Mantz CA, Abu Shahin F, Sandadi S, Orr J., 2015, ASTRO Annual Meeting
Z061520151
Kestin L, Fernandez E, Mantz C, Olivera G, Mo X, Key S, Finkelstein SE, Martinez A, Galmarini D., 2015, ASTRO Annual Meeting
Z050320164
Contantine A. Mantz, 2016, ASTRO
Z12820161
Daniel A. Hamstra, Dhiren Shah, Steven Kurtzman, John Sylvester, Shawn H. Zimberg, Richard S. Hudes, LawrenceIvan Karsh, Mark D. Logsdon, David Beyer, Michael Kos, R. Alex Hsi, Kevin Forsythe, Edward M Soffen, Patrick MFrancke, Hong Zhang, Theodore L. DeWeese, Rodney J. Ellis, Jeffrey Bogart, Constantine Mantz, Neil Mariados, 2017, Genitourinary Cancers Symposium
Z11120172
Mantz Constantine, Wallner Paul, Fernandez Eduardo B., Salenius Sharon, 2017, AAPM Spring Clinical Meeting
Z11120171
Mantz, Constantine, 2017, ACRO
Z2920162
Ron R. Allison, Sharon A. Salenius, Andrej Hnatov, Cynthia Ballenger, Anesa Ahamad, Constantine A. Mantz, Eduardo Fernandez, Steven E. Finkelstein, 2016, American Radium Society 100th Anniversary Meeting
61520157
Myslicki FA, Salenius SA, Shore ND, Mantz CA, Fernandez E, Finkelstein SE, 2015, ACRO Annual Meeting
50820193
A.T. Dang, C.R. King, D. Shabsovich, C.A. Mantz, K.L. Stephans, D.A. Loblaw, P. Cheung, M. Scorsetti, L. Cozzi, A.S. DeNittis, Y. Wang, N. Nickols, P.A. Kupelian, M.L. Steinberg, A.U. Kishan, 2018, ASTRO
50820192
N. Jiang, C.R. King, A.T. Dang, Y. Yuan, S.P. Collins, S. Suy, C.A. Mantz, L. Miszczyk, A. Napieralska, A. Namysl-Kaletka, N.G. Nickols, D. Shabsovich, M.L. Steinberg, P.A. Kupelian, A.U. Kishan, 2018, ASTRO
50820191
A.U. Kishan, A. Katz, C.A. Mantz, F.I. Chu, L. Appelbaum, D.A. Loblaw, I.D. Kaplan, H.T. Pham, M.K. Buyyounouski, D.B. Fuller, R. Meier, S.P. Collins, N. Shaverdian, A.T. Dang, Y. Yuan, H.P. Bagshaw, N.D. Prionas, N. Nickols, M.L. Steinberg, C.R. King, 2018, ASTRO
42620192
Naomi Jiang, Jessica Wong, Eric Horwitz, Richard Stock, Sean Collins, Simeng Suy, Constantine Mantz, Alan Katz, Leszek Miszczyk, Hilary Bagshaw, Nicolas Prionas, Mark Buyyounouski, Nicholas Zaorsky, Nicholas Nickols, Christopher King, Michael Steinberg, Patrick Kupelian, D. Jeffrey Demanes, Amar Kishan, 2019, ASTRO
4262019
Constantine Mantz, 2019, ASTRO
4252019
Lawrence I Karsh, Andrew J Armstrong, Christopher Pieczonka, Shaker Dakhil, Jeffrey Vacirca, Nicholas J Vogelzang, Raoul S Concepcion, James Bailen, Constantine Mantz, Ronald F Tutrone, Nancy N. Chang, Hong Tang, Bruce Brown, Mark C Scholz, 2019, AUA
In the media
Immunotherapy costs drive Medicare spending increase for end-of-life cancer care
April 14, 2023
MRIdian® by Viewray: Cancer treatment in Fort Myers
MRIdian® is the first MR-guided radiotherapy system with peer-reviewed evidence demonstrating reduced side effects and extended survival by decreasing treatment volumes and delivering ablative doses.
Your treatment will be provided by Dr. Constantine Mantz, one of our leading radiation oncologists who is specially trained to provide radiation therapy using the MRIdian®. They’ll work with a team who are also experts in this kind of advanced radiation therapy to review your referral and create a personalized treatment plan tailored to your needs.
